z-logo
open-access-imgOpen Access
Risk Quantification in Antiphospholipid Syndrome
Author(s) -
Doruk Erkan
Publication year - 2010
Publication title -
women s health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.363
H-Index - 39
eISSN - 1745-5065
pISSN - 1745-5057
DOI - 10.2217/whe.10.2
Subject(s) - medicine , lupus anticoagulant , myocardial infarction , stroke (engine) , antiphospholipid syndrome , odds ratio , thrombosis , cardiology , systemic lupus erythematosus , disease , mechanical engineering , engineering
Evaluation of: Urbanus RT, Siegerink B, Roest M, Rosendaal FR, de Groot PG, Algra A: Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case–control study. Lancet Neurol. 8(11), 998–1005 (2009). In a multicenter, population-based case-control study of women younger than 50 years of age, 175 patients with ischemic stroke, 203 patients with myocardial infarction and 628 healthy controls were analyzed. Lupus anticoagulant positivity increased the odds ratio (OR) of ischemic stroke (OR: 43.1; 95% CI: 12.2-152) and myocardial infarction (OR: 5.3; 95% CI: 1.4-20.8). Moreover, additional traditional thrombosis risk factors, such as smoking or oral contraceptives, further increased the OR of ischemic stroke and myocardial infarction in lupus anticoagulant-positive patients, supporting the evidence in support of a multifactorial nature of thrombosis in antiphospholipid antibody-positive patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom